Answers are grounded in this paper and cite their sources.
The growing demand for innovative biotherapeutics requires comprehensive characterization of novel probiotic strains with desirable health-promoting attributes and established safety profiles. This study provides genomic and physicochemical analyses of the exopolysaccharide (EPS) producing strain Lactiplantibacillus plantarum RSM51, evaluating its probiotic potential and biopolymer characteristics. Whole-genome sequencing (WGS) of isolate Lb. plantarum RSM51 was performed, and the assembled genome comprises 3.37 Mbp with a GC content of 44.35%. To investigate the genetic basis of EPS production, the genome was systematically screened for gene clusters associated with EPS biosynthesis. The in silico analysis predicted a complement of genes encoding glycosyltransferases, polymerization enzymes, and transport machinery potentially involved in heteropolysaccharide assembly and export. Furthermore, the crude EPS yield of Lb. plantarum RSM51 was approximately 410 mg/L. Physicochemical characterization of the crude biopolymer, designated EPS-RSM51, by Fourier-transform infrared (FTIR) spectroscopy indicated a polysaccharide structure. Scanning electron microscopy (SEM) of the EPS exhibited an irregular, porous, and amorphous morphology. Elemental analysis via Energy-dispersive X-ray (EDX) spectroscopy showed the polymer was primarily composed of carbon and oxygen, with minor amounts of nitrogen and phosphorus. Moreover, crude EPS-RSM51 exhibited moderate antioxidant activity, with an IC 50 of 5.84 mg/mL in the DPPH assay, 1.70 mg/mL in the FRAP assay, and 3.64 mg/mL in the NO assay. Additionally, crude EPS-RSM51 revealed potent inhibition of α-amylase (IC 50 = 3.28 mg/mL) and α-glucosidase (IC 50 = 3.12 mg/mL). Therefore, this study provides insight into the predicted EPS biosynthetic capacity and the experimentally determined physicochemical properties of EPS-RSM51, thereby supporting the evidence-based integration of crude EPS-RSM51 into functional food and nutraceutical applications.
No takes yet. Share an insight, caveat, or question.
Halfawy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: